종근당홀딩스

Business Overview

JonggeunDang Holdings became a holding company through a corporate split in 2013, owning key subsidiaries such as JonggeunDang, Kyungbo Pharmaceuticals, and JonggeunDang Bio. Its primary revenue streams include management fees, brand usage fees, and dividends, with a strategy focused on specialized business areas to enhance corporate and shareholder value. Major subsidiaries operate in diverse sectors like raw pharmaceutical materials, finished drugs, and health functional foods.